G1 Therapeutics, Inc.
GTHXDelisted Sep 18, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001560241
G1 Therapeutics, Inc. was delisted on Sep 18, 2024; its insiders filed their last Form 4 on Sep 18, 2024; 88 institutions reported holding it in 13F filings for Q2 2024, worth $45.5M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in G1 Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 108
- −6 vs. Q3 2021
- Shares held
- 26.5M
- −157.6K (−0.6%) vs. Q3 2021
- Total value
- $270.6M
- −$87.2M (−24.4%) vs. Q3 2021
- New holders
- 12
- 41 more added
- Sold out
- 18
- 35 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GTHX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 88 | $45.5M |
| Q1 2024 | 86 | $61.6M |
| Q4 2023 | 87 | $38.5M |
| Q3 2023 | 72 | $15.8M |
| Q2 2023 | 80 | $38.6M |
| Q1 2023 | 97 | $51.5M |
| Q4 2022 | 116 | $125.1M |
| Q3 2022 | 104 | $287.5M |
| Q2 2022 | 98 | $98.2M |
| Q1 2022 | 115 | $183.8M |
| Q4 2021 | 108 | $270.6M |
| Q3 2021 | 115 | $357.8M |
| Q2 2021 | 114 | $541.8M |
| Q1 2021 | 123 | $582.2M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding G1 Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Price T Rowe Associates Inc | 834,427 | $8.52M | 0.00% | +10,685+1.3% | Added |
| MPM Oncology Impact Management LP | 856,798 | $8.75M | 1.59% | −3,704−0.4% | Reduced |
| Lombard Odier Asset Management (Switzerland) SA | 1,049,947 | $10.7M | 0.68% | +88,808+9.2% | Added |
| JPMorgan Chase & Co | 2,143,684 | $21.9M | 0.00% | −95,995−4.3% | Reduced |
| Fisher Asset Management, LLC | 2,268,074 | $23.2M | 0.01% | +529,863+30.5% | Added |
| Vanguard Group Inc | 2,544,365 | $26.0M | 0.00% | +38,297+1.5% | Added |
| BlackRock Inc. | 3,310,212 | $33.8M | 0.00% | +68,127+2.1% | Added |
| State Street Corp | 4,301,613 | $43.9M | 0.00% | −81,999−1.9% | Reduced |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −156,507−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −51,899−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −46,900−100.0% | Sold out |
| ETF Managers Group, LLC | 0 | $0 | 0.00% | −43,446−100.0% | Sold out |
| Massachusetts Financial Services Co | 0 | $0 | 0.00% | −39,401−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −27,560−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −26,211−100.0% | Sold out |
| Towercrest Capital Management | 0 | $0 | 0.00% | −17,500−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −16,556−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −11,461−100.0% | Sold out |
| Abbot Financial Management, Inc. | 0 | $0 | 0.00% | −10,650−100.0% | Sold out |
| Exane Derivatives | 0 | $0 | 0.00% | −9,087−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −6,363−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −1,347−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −965−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Center for Financial Planning, Inc. | 0 | $0 | 0.00% | −101−100.0% | Sold out |
| First Horizon Advisors, Inc. | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Sonora Investment Management, LLC | – | – | – | – | Not filed |